Starling Oncology, Inc. Accounts Receivable, Allowance for Credit Loss
Starling Oncology, Inc. (STLN) had Accounts Receivable, Allowance for Credit Loss of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |